StageZero Life Sciences Ltd banner

StageZero Life Sciences Ltd
OTC:SZLSF

Watchlist Manager
StageZero Life Sciences Ltd Logo
StageZero Life Sciences Ltd
OTC:SZLSF
Watchlist
Price: 0.001 USD Market Closed
Market Cap: $403.3k

Wall St Price Targets

SZLSF Price Targets Summary
StageZero Life Sciences Ltd

There are no price targets for SZLSF.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
StageZero Life Sciences Ltd Competitors:
Price Targets
ULTA
Ulta Beauty Inc
19% Upside
CIGI
Colliers International Group Inc
2% Upside
CFFN
Capitol Federal Financial Inc
13% Upside
1981
Cathay Media and Education Group Inc
64% Upside

Revenue
Forecast

28% / Year
Past Growth
22% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
28% / Year
Past Growth
22% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 12 years, the compound annual growth rate for Revenue has been 28%. The projected CAGR for the next 2 years is 22%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for StageZero Life Sciences Ltd

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Operating Income Forecast
is not available for StageZero Life Sciences Ltd

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for StageZero Life Sciences Ltd

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Net Income Forecast
is not available for StageZero Life Sciences Ltd
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is SZLSF's stock price target?
Not Available

SZLSF does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for StageZero Life Sciences Ltd?
Projected CAGR
22%

Over the last 12 years, the compound annual growth rate for Revenue has been 28%. The projected CAGR for the next 2 years is 22%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett